Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18528199 | 1.00 | — | — | |
| SCHEMBL3168 | 0.98 | — | — | |
| SCHEMBL12524834 | 0.98 | — | — | |
| Fluoride SCHEMBL7750151 | 0.98 | — | — | |
| SCHEMBL7097741 | 0.98 | — | — | |
| SCHEMBL322796 | 0.98 | — | — | |
| Bromide SCHEMBL1608720 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL331668 | 0.95 | — | — | |
| Water SCHEMBL7481154 | 0.95 | — | — | |
| SCHEMBL3663947 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113277954-B | Amino acid metal chelate micro-nano powder and preparation method thereof | 英德市匠心新材料股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-105228606-A | Composition of alpha-2 adrenergic receptor and sigma receptor ligand | ESTEVE LABOR DR | 2016-01-06 | — | — | CN | claimed |
| CN-103052388-A | Use of sigma ligands in opioid-induced hyperalgesia | ESTEVE LABOR DR | 2013-04-17 | — | — | CN | claimed |
| CN-119663385-A | Leveling agent and preparation method thereof, copper electroplating solution and copper electroplating method | 广东东硕科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4304554-A1 | DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES | Aquestive Therapeutics, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| EP-3965721-A1 | TOPICAL COMPOSITIONS | DSM IP Assets B.V. (NL) | 2022-03-16 | — | — | EP | disclosed |
| EP-3965722-A1 | TOPICAL COMPOSITIONS | DSM IP Assets B.V. (NL) | 2022-03-16 | — | — | EP | disclosed |
| WO-2021224203-A1 | THE USE OF HYPERBRANCHED COPOLYMERS FOR BALANCING MICROBIAL GROWTH | DSM IP ASSETS B.V. (NL) | 2021-11-11 | — | — | WO | disclosed |
| WO-2020229262-A1 | TOPICAL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2020-11-19 | — | — | WO | disclosed |
| WO-2020229259-A1 | TOPICAL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2020-11-19 | — | — | WO | disclosed |
| EP-3723714-A1 | PROPANEDIOL MONOACETATE MONONITRATE | DSM IP Assets B.V. (NL) | 2020-10-21 | — | — | EP | disclosed |
| EP-2892339-A1 | NOVEL COMPOSITIONS COMPRISING P-HYDROXYBENZYLAMINE | DSM IP Assets B.V. (NL) | 2015-07-15 | — | — | EP | disclosed |
| WO-2014032954-A1 | NOVEL COMPOSITIONS COMPRISING P-HYDROXYBENZYLAMINE | DSM IP ASSETS B.V. (NL) | 2014-03-06 | — | — | WO | disclosed |
| CN-102066333-A | 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors | ESTEVE LABOR DR | 2011-05-18 | — | — | CN | disclosed |
| EP-1509220-A4 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORRHEA CONTAINING 4-HYDROXY-5-METHOXY-4- 2-METHYL-3(3-METHYL-2-BUTENYL)-2-OXIRANYL -1-OXASPIRO 2,5 OCTAN-6-ONE | MYCOPLUS CO LTD (KR) | 2009-04-01 | — | — | EP | disclosed |
| EP-1509220-A1 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORRHEA CONTAINING 4-HYDROXY-5-METHOXY-4- 2-METHYL-3(3-METHYL-2-BUTENYL)-2-OXIRANYL]-1-OXASPIRO 2,5]OCTAN-6-ONE | Mycoplus Co., Ltd. (KR) | 2005-03-02 | — | — | EP | disclosed |
| CN-1466572-A | Pyrrole derivatives | ס����ҩ��ʽ���� | 2004-01-07 | — | — | CN | disclosed |
| WO-2003094908-A1 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORRHEA CONTAINING 4-HYDROXY-5-METHOXY-4-[2-METHYL-3(3-METHYL-2-BUTENYL)-2-OXIRANYL]-1-OXASPIRO[2,5]OCTAN-6-ONE | MYCOPLUS CO., LTD. (KR) | 2003-11-20 | — | — | WO | disclosed |
| EP-1360146-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | Clariant International Ltd. (CH) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002055434-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SUSPENSIONS OF ANIONIC COLLOIDAL SILICA HAVING A NEUTRAL PH AND APPLICATIONS THEREOF | CLARIANT FINANCE (BVI) LIMITED (VG) | 2002-07-18 | — | — | WO | disclosed |